Cosm

Series-B+
cosm.care Biotech & Healthcare
Total Funding $100M
Latest Round $100M Series-B+
Last Announced Jun 24, 2026
Investors Undisclosed
Decision Makers 6 Verified

About Cosm

Cosm develops Gynethotics™ pessaries, which are personalized solutions for prolapse and incontinence. The company provides software and 3D printing technology that enable clinicians to personalize these pessaries for patients. Cosm's customers are clinicians and patients seeking treatment for pelvic floor disorders.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website cosm.care
Domain Registered Date Nov 1, 2017

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $100,000,000 · Series-B+

    fundraisingfox.com

  2. Milestone

    Website domain registered

    cosm.care

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Cosm.

Funding History

1 Round
Series-B+ · Jun 24, 2026

Founders & Leadership

1

Derek Sham

Founder & CEO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts